These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34764039)

  • 1. Results of Second Round Lung Cancer Screening by Low-Dose CT scan - French Cohort Study (DEP-KP80).
    Leleu O; Basille D; Auquier M; Clarot C; Hoguet E; Baud M; Lenel S; Milleron B; Berna P; Jounieaux V
    Clin Lung Cancer; 2022 Jan; 23(1):e54-e59. PubMed ID: 34764039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung Cancer Screening by Low-Dose CT Scan: Baseline Results of a French Prospective Study.
    Leleu O; Basille D; Auquier M; Clarot C; Hoguet E; Pétigny V; Addi AA; Milleron B; Chauffert B; Berna P; Jounieaux V
    Clin Lung Cancer; 2020 Mar; 21(2):145-152. PubMed ID: 31982356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung cancer screening by low-dose CT scan in France: final results of the DEP KP80 study after three rounds.
    Leleu O; Storme N; Basille D; Auquier M; Petigny V; Berna P; Letierce A; Couraud S; de Bermont J; Milleron B; Jounieaux V
    EBioMedicine; 2024 Nov; 109():105396. PubMed ID: 39396424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors for the participation of general practitioners in lung cancer screening by low-dose CT scan in the Somme department in northern France.
    Leleu O; Vincent G; Auquier M; Basille D; Clarot C; Hoguet E; Pétigny V; Duban P; Zerkly S; Ganry O; Chauffert B; Berna P; Jounieaux V
    Respir Med Res; 2020 Mar; 77():95-99. PubMed ID: 32512523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological impact of lung cancer screening by low dose CT scan in the French Department of the SOMME.
    Addi AA; Leleu O; Basille D; Lapôtre-Ledoux B; Auquier M; Ganry O; Berna P; Jounieaux V
    Respir Med Res; 2022 May; 81():100887. PubMed ID: 35219227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavior of general physicians about lung cancer screening in a French region hosting a pilot study.
    Marchal E; Burgaud C; Jounieaux V; Leleu O
    Respir Med Res; 2023 Jun; 83():100992. PubMed ID: 36812773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LUCSO-1-French pilot study of LUng Cancer Screening with low-dose computed tomography in a smokers population exposed to Occupational lung carcinogens: study protocol.
    Delva F; Laurent F; Paris C; Belacel M; Brochard P; Bylicki O; Chouaïd C; Clin B; Dewitte JD; Le Denmat V; Gehanno JF; Lacourt A; Margery J; Verdun-Esquer C; Mathoulin-Pélissier S; Pairon JC
    BMJ Open; 2019 Mar; 9(3):e025026. PubMed ID: 30904859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized study on early detection of lung cancer with MSCT in Germany: study design and results of the first screening round.
    Becker N; Motsch E; Gross ML; Eigentopf A; Heussel CP; Dienemann H; Schnabel PA; Pilz L; Eichinger M; Optazaite DE; Puderbach M; Tremper J; Delorme S
    J Cancer Res Clin Oncol; 2012 Sep; 138(9):1475-86. PubMed ID: 22526165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Economic impact of lung cancer screening in France: A modeling study].
    Gendarme S; Perrot É; Reskot F; Bhoowabul V; Fourre G; Souquet PJ; Milleron B; Couraud S
    Rev Mal Respir; 2017 Sep; 34(7):717-728. PubMed ID: 26585377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
    Horeweg N; Scholten ET; de Jong PA; van der Aalst CM; Weenink C; Lammers JW; Nackaerts K; Vliegenthart R; ten Haaf K; Yousaf-Khan UA; Heuvelmans MA; Thunnissen E; Oudkerk M; Mali W; de Koning HJ
    Lancet Oncol; 2014 Nov; 15(12):1342-50. PubMed ID: 25282284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and efficacy of early lung cancer diagnosis with chest computed tomography in HIV-infected smokers.
    Makinson A; Eymard-Duvernay S; Raffi F; Abgrall S; Bommart S; Zucman D; Valour F; Cheret A; Poizot-Martin I; Duvivier C; Mauboussin JM; Bonnet F; Tattevin P; Reynes J; Le Moing V;
    AIDS; 2016 Feb; 30(4):573-82. PubMed ID: 26829006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis.
    Rampinelli C; De Marco P; Origgi D; Maisonneuve P; Casiraghi M; Veronesi G; Spaggiari L; Bellomi M
    BMJ; 2017 Feb; 356():j347. PubMed ID: 28179230
    [No Abstract]   [Full Text] [Related]  

  • 13. Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval.
    Yousaf-Khan U; van der Aalst C; de Jong PA; Heuvelmans M; Scholten E; Lammers JW; van Ooijen P; Nackaerts K; Weenink C; Groen H; Vliegenthart R; Ten Haaf K; Oudkerk M; de Koning H
    Thorax; 2017 Jan; 72(1):48-56. PubMed ID: 27364640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of screening for lung cancer in Australia.
    Marshall HM; Finn N; Bowman RV; Passmore LH; McCaul EM; Yang IA; Connelly L; Fong KM
    Intern Med J; 2019 Nov; 49(11):1392-1399. PubMed ID: 31336016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
    Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
    Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral arterial disease and systematic detection of circulating tumor cells: rationale and design of the DETECTOR prospective cohort study.
    Yannoutsos A; Fontaine M; Galloula A; Damotte D; Chatellier G; Paterlini-Bréchot P; Meyer G; Pastre J; Duchatelle V; Marini V; Schwering KL; Lazareth I; Ghaffari P; Stansal A; Sanson H; Labrousse C; Beaussier H; Nasr NB; Zins M; Salmeron S; Messas E; Lajonchère JP; Emmerich J; Priollet P; Trédaniel J
    BMC Cardiovasc Disord; 2019 Sep; 19(1):212. PubMed ID: 31519196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study.
    Marquette CH; Boutros J; Benzaquen J; Ferreira M; Pastre J; Pison C; Padovani B; Bettayeb F; Fallet V; Guibert N; Basille D; Ilie M; Hofman V; Hofman P;
    Lancet Respir Med; 2020 Jul; 8(7):709-716. PubMed ID: 32649919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second round results from the Manchester 'Lung Health Check' community-based targeted lung cancer screening pilot.
    Crosbie PA; Balata H; Evison M; Atack M; Bayliss-Brideaux V; Colligan D; Duerden R; Eaglesfield J; Edwards T; Elton P; Foster J; Greaves M; Hayler G; Higgins C; Howells J; Irion K; Karunaratne D; Kelly J; King Z; Lyons J; Manson S; Mellor S; Miller D; Myerscough A; Newton T; O'Leary M; Pearson R; Pickford J; Sawyer R; Screaton NJ; Sharman A; Simmons M; Smith E; Taylor B; Taylor S; Walsham A; Watts A; Whittaker J; Yarnell L; Threlfall A; Barber PV; Tonge J; Booton R
    Thorax; 2019 Jul; 74(7):700-704. PubMed ID: 30420406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
    Tammemagi MC; Schmidt H; Martel S; McWilliams A; Goffin JR; Johnston MR; Nicholas G; Tremblay A; Bhatia R; Liu G; Soghrati K; Yasufuku K; Hwang DM; Laberge F; Gingras M; Pasian S; Couture C; Mayo JR; Nasute Fauerbach PV; Atkar-Khattra S; Peacock SJ; Cressman S; Ionescu D; English JC; Finley RJ; Yee J; Puksa S; Stewart L; Tsai S; Haider E; Boylan C; Cutz JC; Manos D; Xu Z; Goss GD; Seely JM; Amjadi K; Sekhon HS; Burrowes P; MacEachern P; Urbanski S; Sin DD; Tan WC; Leighl NB; Shepherd FA; Evans WK; Tsao MS; Lam S;
    Lancet Oncol; 2017 Nov; 18(11):1523-1531. PubMed ID: 29055736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A population-based cohort study to evaluate the effectiveness of lung cancer screening using low-dose CT in Hitachi city, Japan.
    Nawa T; Fukui K; Nakayama T; Sagawa M; Nakagawa T; Ichimura H; Mizoue T
    Jpn J Clin Oncol; 2019 Feb; 49(2):130-136. PubMed ID: 30541133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.